Cargando…

A Comparison of the Biological Features of Prostate Cancer with (PSA+, PSMA+) Profile according to RKIP

Purpose. To investigate differences in the biological features of the most immunoexpressed prostate cancer (PC) profiles (PSA+, PSMA+) according to the RKIP. Methods. 19 PC with dominant Gleason grade ≥8 were studied. Expression of PSA, PSMA, RKIP, Raf-1, MEK-1, ERK-1, ERK-2, p-Akt (T308), p-Akt (S4...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ben Jemaa, Awatef, Bouraoui, Yosra, Sallami, Sataa, Nouira, Yassine, Oueslati, Ridha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749534/ https://www.ncbi.nlm.nih.gov/pubmed/23991415 http://dx.doi.org/10.1155/2013/409179

Ejemplares similares

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
por: Ben Jemaa , Awatef, et al.
Publicado: (2010)

Intraprostatic Hydatid Cyst: An Unusual Presentation
por: Nouira, Yassine, et al.
Publicado: (2006)

ERα and ERβ co-expression: An indicator of aggressive tumors and hormonal sensitivity
por: Oueslati, Mohamed, et al.
Publicado: (2017)

Evaluation of individual and combined NLR, LMR and CLR ratio for prognosis disease severity and outcomes in patients with COVID-19
por: Ben Jemaa, Awatef, et al.
Publicado: (2022)

Insights of RKIP-Derived Suppression of Prostate Cancer
por: Dong, Ying, et al.
Publicado: (2021)

The biological complexity of RKIP signaling in human cancers
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2015)

Diagnostic Efficacy of PSMA and PSCA mRNAs Combined to PSA in Prostate Cancer Patients
por: Mahmoud, Mustafa M, et al.
Publicado: (2023)

RKIP Regulates Differentiation-Related Features in Melanocytic Cells
por: Penas, Cristina, et al.
Publicado: (2020)

Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer
por: von Eyben, Rie, et al.
Publicado: (2023)

PSA and PSA Kinetics Thresholds for the Presence of (68)Ga-PSMA-11 PET/CT-Detectable Lesions in Patients with Biochemical Recurrent Prostate Cancer
por: Hoffmann, Manuela Andrea, et al.
Publicado: (2020)

Comparison of [(18)F]PSMA-1007 with [(68)Ga]Ga-PSMA-11 PET/CT in Restaging of Prostate Cancer Patients with PSA Relapse
por: Hoffmann, Manuela A., et al.
Publicado: (2022)

Comparison of percentage free PSA, MRI and GaPSMA PET scan for diagnosing cancer prostate in men with PSA between 4 and 20 ng/ml
por: Kumar, Niraj, et al.
Publicado: (2019)

The Impact of PSMA-PET on Oncologic Control in Prostate Cancer Patients Who Experienced PSA Persistence or Recurrence
por: Bianchi, Lorenzo, et al.
Publicado: (2022)

EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate Cancer
por: Falkenbach, Fabian, et al.
Publicado: (2023)

Strangulation of the Penis by a Metallic Ring: Prevention Is Better Than Cure
por: Ichaoui, Hamza, et al.
Publicado: (2018)

Metastatic-directed therapy using PSMA-PET/CT at PSA relapse
por: Lilleby, Oscar, et al.
Publicado: (2019)

Clinical Variables Associated with PSA Response to Lutetium-177-PSMA ([177Lu]-PSMA-617) Radionuclide Treatment in Men with Metastatic Castration-Resistant Prostate Cancer
por: Gadot, Moran, et al.
Publicado: (2020)

Antihormone treatment differentially regulates PSA secretion, PSMA expression and (68)Ga–PSMA uptake in LNCaP cells
por: Mathy, C. S., et al.
Publicado: (2021)

PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml
por: Solomonidou, Nantia, et al.
Publicado: (2023)

Can the Gleason score be predicted in patients with prostate cancer? A dynamic contrast-enhanced MRI, ((68))Ga-PSMA PET/CT, PSA, and PSA-density comparison study
por: Akkaya, Hüseyin, et al.
Publicado: (2023)

Practice Patterns of Korean Urologists for Screening and Managing Prostate Cancer according to PSA Level
por: Chung, Mun Su, et al.
Publicado: (2012)

Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma
por: Papale, Massimo, et al.
Publicado: (2017)

A case report of multiple foreign body ingestion with a ring-like configuration: The magnetic effect
por: Mili, Takwa, et al.
Publicado: (2023)

What to Trust, PSA or [(68)Ga]Ga-PSMA-11: Learn from Experience
por: Viglialoro, Rita, et al.
Publicado: (2021)

Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
por: Höti, Naseruddin, et al.
Publicado: (2023)

Functional Linkage of RKIP to the Epithelial to Mesenchymal Transition and Autophagy during the Development of Prostate Cancer
por: Ahmed, Mahmoud, et al.
Publicado: (2018)

TROY interacts with RKIP to promote glioma development
por: Liu, Xiujie, et al.
Publicado: (2018)

Harnessing RKIP to Combat Heart Disease and Cancer
por: Lorenz, Kristina, et al.
Publicado: (2022)

The Role of RKIP in the Regulation of EMT in the Tumor Microenvironment
por: Cessna, Hannah, et al.
Publicado: (2022)

Volvulus gastrique aigu compliquant une hernie diaphragmatique congénitale chez un nourrisson de 3 mois: à propos d’un cas
por: Mili, Takwa, et al.
Publicado: (2022)

A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis
por: von Eyben, Rie, et al.
Publicado: (2022)

Treatment of local–regional prostate cancer detected by PSA screening: benefits and harms according to prognostic factors
por: Wever, E M, et al.
Publicado: (2013)

The positivity rate of 68Gallium-PSMA-11 ligand PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer
por: Hoffmann, Manuela A., et al.
Publicado: (2019)

Is there more than meets the eye in PSMA imaging in prostate cancer with PET/MRI? Looking closer at uptake time, correlation with PSA and Gleason score
por: Bogdanovic, Borjana, et al.
Publicado: (2023)

Deciphering the balance of IL-6/IL-10 cytokines in severe to critical COVID-19 patients
por: Azaiz, Mouna Ben, et al.
Publicado: (2022)

Biological and therapeutic implications of RKIP in Gastrointestinal Stromal Tumor (GIST): an integrated transcriptomic and proteomic analysis
por: Campanella, Nathália Cristina, et al.
Publicado: (2023)

Prognostic value of RKIP and p-ERK in gastric cancer
por: Fujimori, Yoshitaka, et al.
Publicado: (2012)

Regulation of RKIP Function by Helicobacter pylori in Gastric Cancer
por: Moen, Erika L., et al.
Publicado: (2012)

RKIP as an Inflammatory and Immune System Modulator: Implications in Cancer
por: Gabriela-Freitas, Maria, et al.
Publicado: (2019)

RKIP: A Pivotal Gene Product in the Pathogenesis of Cancer
por: Bonavida, Benjamin
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mpnm3ctssrkub996nhqive75kg